The new and updated analyser has been designed to enhance usability with the latest colour, touch screen and advanced connectivity, enabling the Biosen to seamlessly connect with hospital and laboratory IT systems, via EKF Link, to ensure patient results are quickly and securely available to clinicians.

The Biosen analyser measures glucose and lactate levels in whole blood, plasma and serum, using enzymatic sensor technology to give highly precise results, less than 3% CV. It is used by clinical professionals in both primary and secondary care settings around the world to provide glucose analysis for the detection and management of diabetes, a chronic condition which is expected to affect 1.31 billion people worldwide by 2050 according to the company.